Fatty acid metabolism in marine fish: Low activity of fatty acyl Δ5 desaturation in gilthead sea bream ( Sparus aurata ) cells by Tocher, Douglas R & Ghioni, Cristina
 Fatty Acid Metabolism in Marine Fish: Low Activity of Fatty Acyl 
Δ5 Desaturation in Gilthead Sea Bream (Sparus aurata) Cells 
 
Douglas R. Tocher*, and Cristina Ghioni 
Unit of Aquatic Biochemistry, Institute of Aquaculture, University of Stirling, Stirling FK9 
4LA, Scotland 
 
 
*To whom correspondence should be addressed. 
Tel. +44 1786 467996 
Fax +44 1786 472133 
E-mail: d.r.tocher@stir.ac.uk 
 
Key words: Polyunsaturated fatty acids, desaturase, elongase, marine fish, cell culture, sea 
bream, Sparus aurata.  
 
Running title: Low Δ5 desaturase in sea bream cells 
 
Abbreviations:  ANOVA, analysis of variance; BHT, butylated hydroxytoluene; BSA, bovine 
serum albumin; CL, cardiolipin; FBS, fetal bovine serum; GC, gas chromatography; HBSS, 
Hank’s balanced salt solution (without Ca2+ and Mg2+); HPTLC, high-performance thin-layer 
chromatography;  HUFA, highly unsaturated fatty acids (≥ C20 with ≥ 3 double bonds); PA, 
phosphatidic acid; PBS, Dulbecco’s modification phosphate buffered saline (without Ca2+ and 
  
2 
2 
Mg2+); PC, phosphatidylcholine; PE,phosphatidylethanolamine; PI, phosphatidylinositol; PS, 
phosphatidylserine; PUFA, polyunsaturated fatty acid; TLC, thin-layer chromatography; TN, 
total neutral lipid; TP, total polar lipid. 
 
 ABSTRACT:   Marine fish are known to have an absolute dietary requirement for C20 
and C22 highly unsaturated fatty acids.  Previous studies using cultured cell lines indicated that 
underlying this requirement in marine fish was either a deficiency in fatty acyl Δ5 desaturase or 
C18-20 elongase activity.  Recently, Ghioni et al. (Biochim. Biophys. Acta, 1437, 170-181, 1999) 
presented evidence that in turbot cells there was low activity of C18-20 elongase whereas Δ5 
desaturase had high activity.  In the present study, the fatty acid desaturase/elongase pathway 
was investigated in a cell line (SAF-1) from another carnivorous marine fish, sea bream. The 
metabolic conversions of a range of radiolabelled polyunsaturated fatty acids that comprised the 
direct substrates for Δ6 desaturase ([1-14C]18:2n-6 and [1-14C]18:3n-3), C18-20 elongase ([U-
14C]18:4n-3), Δ5 desaturase ([1-14C]20:3n-6 and [U-14C]20:4n-3) and C20-22 elongase ([1-
14C]20:4n-6 and [1-14C]20:5n-3) were utilized.  The results showed that fatty acyl Δ6 desaturase 
in SAF-1 cells was highly active and there was substantial C18-20 elongase and  C20-22 elongase 
activities.  A deficiency in the desaturation/elongation pathway was clearly identified at the 
level of the fatty acyl Δ5 desaturase which was very low, particularly with 20:4n-3 as substrate.  
In comparison, the apparent activities of Δ6 desaturase, C18-20 elongase and C20-22 elongase were 
approximately 94-fold, 27-fold and 16-fold greater than that for Δ5 desaturase towards their 
respective n-3 polyunsaturated fatty acid substrates.  The evidence obtained in the SAF-1 cell 
line is consistent with the dietary requirement for C20 and C22 highly unsaturated fatty acids in 
the marine fish, the sea bream, being primarily due to a deficiency in fatty acid Δ5 desaturase 
activity. 
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The essential fatty acid (EFA) requirements of freshwater and marine fish have long been 
known to be qualitatively different, as in freshwater fish 18:3n-3 and/or 18:2n-6 can satisfy the 
EFA requirement, whereas marine species required the longer chain HUFA (highly unsaturated 
fatty acids) 20:5n-3 and 22:6n-3 to be supplied by the diet for optimal growth (1-3). This 
suggested that there was a difference in the fatty acid desaturation/elongation pathway between 
freshwater and marine fish (4,5).  Dietary conversion studies performed on turbot in vivo  
indicated that marine fish were unable to produce 20:4n-6 and 20:5n-3 from dietary 18:2n-6 and 
18:3n-3, respectively (6-8). However, the in vivo experiments were unable to precisely 
distinguish the location of any potential deficiency in the fatty acid desaturation/elongation 
pathway.  
 It was shown that the difference in fatty acid metabolism between freshwater and marine 
fish observed in vivo was also present in cultured cell lines (9).  Studies involving 
supplementation of turbot cells (TF) in culture, compared to both rainbow trout cells (RTG-2) 
and Atlantic salmon cells (AS), with various n-3 and n-6 polyunsaturated fatty acids (PUFA) 
showed that a relative deficiency in the desaturase/elongase pathway in TF cells was located 
either at the C18 to C20 elongase (C18-20 elongase) multi-enzyme complex or the fatty acyl Δ5 
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desaturase (9,10).  In order to establish more precisely a deficient step in the desaturase/elongase 
pathway, the direct substrates for all the component enzymes in the pathway are required so that 
each activity can be assayed and determined in isolation from the influence of preceding 
activities in the pathway. However,  isotopes for two crucial fatty acid substrates, 18:4n-3 (the 
direct substrate for C18-20 elongase) and 20:4n-3 (the direct substrate for Δ5 desaturase) were not 
available commercially.   Recently, Ghioni et al. (11) biosynthesized high purity [U-14C]18:4n-3 
and [U-14C]20:4n-3 and provided good evidence that the deficiency in TF cells was located at 
the C18-20 elongase and not the Δ5 desaturase.   
To date, a deficiency in marine fish fatty acid metabolism has only been characterized in 
one species, turbot.  Results from various in vivo studies involving injection of radiolabelled 
fatty acid precursors such as [1-14C]18:3n-3 and [1-14C]20:5n-3 with other species such as 
gilthead sea bream (Sparus aurata) and golden grey mullet (Liza aurata) confirmed that an 
apparent deficiency in the desaturation/elongation pathway was present in those species and 
supported the view that it was common to all marine fish (12-14).   However, as with the in vivo 
studies in turbot, they were unable to identify the specific enzymic location responsible for a 
deficiency in the pathway.  Recently, the availability of a cell line from sea bream, SAF-1, 
combined with the availability of [U-14C]18:4n-3 and [U-14C]20:4n-3 isotopes, has enabled the 
deficiency in the pathway to be characterized in another marine fish. We report here that,  in 
contrast to turbot cells, the primary deficiency in the desaturation/elongation pathway in SAF-1 
cells from gilthead sea bream was clearly identified at the level of the fatty acyl Δ5 desaturase. 
 
MATERIALS AND METHODS 
Cell line and culture conditions. The gilthead seabream (Sparus  aurata L.) cell line, SAF-1, 
developed from fin tissue without immortalization was kindly provided by Dr. M.C. Alvarez 
(Department of Cell Biology and Genetics, University of Malaga, Spain) (15).  The cell line 
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displays fibroblast-like morphology and had been subcultured approximately 120 times over a 
two year period. Karyotype and DNA content indicate a predominantly euploid and stable cell 
population.   The cells were routinely maintained in Leibovitz L-15 medium supplemented with 
2 mM glutamine, antibiotics (50 I.U. ml-1 penicillin and 50 mg.ml-1 streptomycin) and 10% fetal 
bovine serum (FBS).  Cells were cultured at 22oC in 75 cm2 sealed plastic tissue culture flasks 
(Corning Costar, High Wycombe, U.K.) and were routinely subcultured within 24 h of reaching 
confluence at a seeding density of 1 x 105 cells.cm-2.   Unless otherwise stated, for each 
experimental sample, 3 x 75 cm2 flasks were seeded and this experiment was repeated three 
times to obtain the replicates.  Therefore, all results are means + SD of three such experiments.  
Cell harvesting and lipid extraction.  Medium was aspirated and the cultures washed twice 
with 20 ml of ice-cold Hanks’ balanced salt solution without calcium and magnesium (HBSS).  
Cells were harvested by trypsinization with 0.05% trypsin/0.5 mM ethylenediamine tetraacetic 
acid (EDTA), washed with 5 ml ice-cold HBSS and samples taken for cell counting (16) and 
protein determination according to the method of Lowry et al. (17) after incubation with 0.25 ml 
of 0.25% (wt/vol) sodium dodecyl sulphate/1 M NaOH for 45 min at 60oC.  The cells were 
washed with 5 ml HBSS containing 1% fatty acid-free bovine serum albumin (FAF-BSA) and 
total lipid extracted from the cell pellets with 5 ml ice-cold chloroform/methanol (2:1, v/v) 
containing 0.01% butylated hydroxytoluene (BHT) as antioxidant, according to Folch et   al. 
(18) as described in detail previously (19). Lipid content was determined gravimetrically after 1 
h vacuum desiccation and the lipid resuspended in chloroform/methanol (2:1, v/v) containing 
BHT at a concentration of 10 mg.ml-1, and samples stored at  -20oC prior to analyses.     
Lipid class  analysis. Lipid classes were separated by one-dimensional, double-
development high-performance thin-layer chromatography (HPTLC) using methyl 
acetate/propan-2-ol/chloroform/methanol/0.25% aqueous KCl (25:25:25:10:9, by vol.) and 
hexane/diethyl ether/acetic acid (85:15;1.5, by vol.) as developing solvents as described 
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previously (20).  Lipid classes were quantified by charring (21) followed by scanning 
densitometry using a Shimadzu  CS-9000 dual wavelength flying spot scanner and DR-2 
recorder (22). 
Fatty acid analyses. Fatty acid methyl esters (FAME) were prepared from total lipid by 
acid-catalyzed transmethylation at 50oC for 16 h (23) and extracted and purified as described 
previously (20).  FAME were analyzed in a Carlo Erba Vega GC6000 gas chromatograph (Carlo 
Erba Strumentazione, Milan, Italy) equipped with a CP Wax 51 fused silica capillary column 
(50 m x 0.32 mm i.d., Chrompack U.K. Ltd., London), with on-column injection using hydrogen 
as carrier gas and a biphasic thermal gradient from 50oC to 225oC.  FAME were identified by 
comparison with known standards and a well-characterized fish oil and by reference to 
published data as described previously and were quantified using a Carlo Erba DP800 data 
processor (20).  All solvents contained 0.01% BHT as an antioxidant. 
Incubation of cultures with 14C-labelled polyunsaturated fatty acids and incorporation of 
radioactivity into total lipid. Cell cultures were routinely grown in 75 cm2 flasks in medium 
containing 10% FBS and subcultured into medium containing 2% FBS 24 h prior to 
experimentation. All experiments were performed in triplicate with three flasks (for [1-
14C]PUFAs) and one flask (for [U-14C]PUFAs) per sample per experiment. The medium was 
aspirated, cultures washed with Dulbecco’s phosphate-buffered saline (PBS) and fresh Leibovitz 
L-15 medium, as above, was added.  The [1-14C]PUFAs (18:2n-6, 18:3n-3, 20:3n-6, 20:4n-6 and 
20:5n-3) (0.25 µCi per flask; concentration, 0.35 µM) were added to the cell cultures bound to 
FAF-BSA in medium (24). The [U-14C]PUFAs (18:4n-3 and 20:4n-3) were both obtained as 
methyl esters and because of the low yield that characterized their production, with little mass 
available, these substrates were added directly as methyl esters in 50 µl of ethanol ) (0.25 µCi 
per flask; concentration approximately 0.1 µM), to avoid the losses associated with 
saponification, purification of unesterified fatty acid and sterile filtration (11). Preliminary 
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experiments incubating cells with 25 µM unlabelled 18:4n-3 as fatty acid salt/BSA complex and 
as methyl ester in ethanol, showed no difference in the metabolism to 20:4n-3, after 6 days of 
culture and no accumulation of methyl ester in cellular lipids (11). Therefore these two ways of 
presenting and delivering radiolabelled PUFA to the cells in culture can be considered 
equivalent under the conditions used in this study. 
After addition of isotope, incubation continued for 6 days at 22oC.   Cells were harvested, 
lipid extracted as above and the radioactive content of total lipid determined in 3 aliquots of 5 µl 
in mini-vials containing 2.5 ml scintillation fluid (Ecoscint A; National Diagnostics, Atlanta, 
U.S.A.) using a TRI-CARB 2000CA liquid scintillation spectrophotometer (United 
Technologies Packard).  Results were corrected for counting efficiency and quenching using an 
appropriate calibration curve.   All solvents contained 0.01% BHT as antioxidant. 
Incorporation of radioactivity into glycerophospholipid classes. Samples of total lipid 
(100 µg) were applied as 1 cm streaks to HPTLC plates, and lipid classes separated by the one-
dimensional, double-development method as described above.   After desiccation, the lipid 
classes were visualized by brief exposure to iodine vapour  and areas corresponding to 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphatidic acid/cardiolipin  (PA/CL) and total neutral lipid (TN; the 
combined free fatty acid, triacylglycerol and steryl ester areas) were scraped into scintillation 
vials containing 2.5 ml scintillation fluid and radioactivity determined as above. 
Incorporation of radioactivity into polyunsaturated fatty acids. Total lipid extracts were 
transmethylated overnight at 50oC in methanolic sulfuric acid (23) and FAME extracted and 
purified as described above. TLC plates were impregnated by spraying with 2 g silver nitrate in 
20 ml acetonitrile and activated at 110oC for 30 min. FAME were applied as 1 cm streaks and 
plates developed with toluene/acetonitrile (95:5, v/v) to separate PUFA (25).   Autoradiography 
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was performed using Kodak MR2 film for 7 days at room temperature. Silica corresponding to 
individual FAME was scraped into scintillation vials containing 2.5 ml scintillation fluid and 
radioactivity determined as described above. 
Preparation  of [U-14C]18:4n-3 and [U-14C]20:4n-3. [U-14C]18:4n-3 was prepared as 
described in detail by Ghioni et al. (1999). Briefly, the unicellular marine alga Isochrysis 
galbana  (Parke) (S.M.B.A. strain No. 58 C.C.A.P. strain 927/1) was incubated with sodium 
[14C]bicarbonate, total lipid extracted, the 18:4-rich glycerolipids (mono- and di-
galactosyldiacylglycerols) purified by TLC, transmethylated and FAME extracted as described 
previously (11, 20). FAME were separated by argentation TLC, individual FAME identified by 
autoradiography and the [U-14C]18:4n-3 methyl ester eluted and quantified (11). [U-14C]20:4n-3 
was biosynthesized from [U-14C]18:4n-3 as described by Ghioni et al. (1999).  Briefly,  Atlantic 
salmon (AS) cells were incubated with [U-14C]18:4n-3 methyl ester, total lipid extracted, 
transmethylated, and FAME separated by argentation TLC as above. Both [U-14C] isotopes had 
specific activities of approximately 12 mCi/mmol and were > 99% pure, determined by radio-
gas chromatography as described by Buzzi et al. (26). 
Materials. Sodium [14C]bicarbonate (~ 50 mCi.mmol-1) was purchased from ICN 
Biomedicals Ltd. (Thame, U.K.). [1-14C] PUFA (all 50-55 mCi.mmol-1 and >98% pure) were 
obtained from NEN Life Science Products (Hounslow, U.K.).   Leibovitz L-15 medium, HBSS, 
PBS, glutamine, penicillin, streptomycin, FBS,  trypsin/EDTA , FAF-BSA and BHT were 
obtained from Sigma Chemical Co. Ltd. (Poole, UK). TLC plates (20 cm x 20 cm x 0.25 mm) 
and HPTLC plates (10 cm x 10 cm x 0.15 mm), pre-coated with silica gel 60 were obtained 
from Merck, (Darmstadt, Germany).  All solvents were of HPLC grade and were obtained from 
Rathburn Chemicals (Walkerburn, Peebleshire,  Scotland). 
Statistical analysis. All results are means + SD of three experiments. Where indicated, 
data were subjected to one-way analysis of variance (ANOVA) and where appropriate the 
  
9 
9 
significance of differences were determined by Tukey’s test.  When necessary, data were 
subjected to arc-sin transformation prior to statistical analysis. Differences are reported as 
significant when p < 0.05 (27). 
RESULTS 
The lipid content and class composition of SAF-1 cells cultured in 10% FBS are shown in Table 
1.  Almost 75% of the total lipid was polar lipid with  almost 30% PC, 19% PE, 7.3% PI and 
6.3% PS whereas the neutral lipid was predominantly cholesterol (20.3%).  The fatty acid 
composition of total lipid of SAF-1 cells contained over 41%  monounsaturated fatty acids, with 
18:1n-9 comprising 25.2%, and approximately 25% saturated fatty acids, predominantly 16:0 
(15%) and 18:0 (8.5%) (Table 2).  The PUFA were characterized by 10% n-9PUFA, 90% of 
which was 18:2n-9 the single most abundant PUFA in the cells, with 11.1% n-3PUFA, mainly 
22:6n-3 and 20:5n-3, and 9.5% n-6PUFA, primarily 20:4n-6. 
The recovery of radioactivity in total lipid from SAF-1 cells incubated with [1-14C]20:5n-3  
was significantly greater than any of the other PUFA investigated (Table 3).  There were 
numerical differences between the other PUFA but, irrespective of the way that the recovery 
data were presented, few were statistically significant although there was a trend for the 
recovery of radioactivity from cells incubated with [1-14C]18:2n-6, [1-14C]18:3n-3 and [1-
14C]20:4n-6 to be higher than the recovery of radioactivity from incubations with [1-14C]18:4n-
3, [1-14C]20:3n-6 and [1-14C]20:4n-3.   All the PUFA were predominantly esterified into the 
main glycerophospholipid classes with between 88% and 98% of radioactivity being recovered 
in these classes (Table 4).  Higher incorporation into the glycerophospholipids was generally 
observed with the C20 PUFA compared to the C18 PUFA.  Both [1-14C]20:4n-6 and [1-14C]20:5n-
3 were predominantly incorporated into PE whereas all the other PUFA were incorporated 
predominantly into PC, these differences being statistically significant (Table 4). Significantly 
more [U-14C]18:4n-3 and [U-14C]20:4n-3 were incorporated into PC compared to the other 
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PUFA and significantly greater proportions of [1-14C]20:4n-6  and, to a lesser extent, [1-
14C]20:3n-6, were incorporated into PI compared to the other PUFA.   
The main metabolic product of [1-14C]18:2n-6 recovered from SAF-1 cells was 18:3n-6 (over 
35% of radioactivity recovered in this fraction) whereas the main metabolic products of [1-
14C]18:3n-3 were 18:4n-3 and 20:4n-3 (almost 41% and 21% of radioactivity recovered in these 
products, respectively) (Table 5).  With all the other PUFA, over 80% of the radioactivity was 
recovered in the form of the fatty acid originally added to the cells.  With [U-14C]18:4n-3, the 
only major products were the elongation products 20:4n-3 (13.2%) and 22:4n-3 (5.1%), with 
only 0.7% being desaturated to 20:5n-3.  Similarly, with [1-14C]20:3n-6,  elongation products 
comprised almost 85% of the total metabolized.  The main products of the metabolism of [U-
14C]20:4n-3 in SAF-1 cells were 22:4n-3 and the chain shortened product, 18:4n-3 (Table 5).  
Both [1-14C]20:4n-6 and [1-14C]20:5n-3 were mainly elongated with only a small fraction of 
radioactivity being recovered as 22:6n-3 in [1-14C]20:5n-3-supplemented cells. Table 6 is a 
summary of the results obtained in the isotope experiments and is derived from the data 
contained in Table 5 but presented as sums of products of each individual step in the 
deaturation/elongation pathway taking into account all the fatty acids that are derived from that 
step, irrespective of subsequent conversions. The results obtained for each enzyme activity when 
incubating the cells with the fatty acid which is its direct substrate (i.e. 18:4n-3 for C18-20 
elongase and 20:4n-3 for Δ5 desaturase) are of particular interest as they show the potential of 
each activity independent of the previous enzymes.  Table 6 shows that considerable amounts of 
radioactivity are recovered as Δ6 desaturase products in SAF-1 cells incubated with the main 
fatty acid substates for Δ6 desaturase, [1-14C]18:3n-3 and [1-14C]18:2n-6.  Although the majority 
of the [1-14C]18:3n-3 and [1-14C]18:2n-6 metabolized to Δ6 desaturase products were not further 
metabolized, about 27% and 9% of the total radioactivity recovered in the case of  [1-14C]18:3n-
3 and [1-14C]18:2n-6, respectively, was elongated by C18-20 elongase.  Very little radioactivity 
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from [1-14C]18:2n-6 and, especially, [1-14C]18:3n-3, was recovered in Δ5 desaturated products.  
When SAF-1 cells were incubated with the direct n-3 substrate of C18-20 elongase, [U-14C]18:4n-
3, 19% was elongated but only 0.7% was recovered in Δ5 desaturated products.  The very low 
activity of fatty acyl Δ5 desaturase in SAF-1 cells was confirmed using direct substrates for Δ5 
desaturase, [1-14C]20:3n-6 and [U-14C]20:4n-3, where little radioactivity was recovered in Δ5 
desaturated products (Table 6). C20-22 elongase products were found in the cells with all the fatty 
acids used and in higher percentages compared to Δ5 desaturation products. 
 
DISCUSSION 
The results of the present study indicate that the sea bream cell line has a deficiency in the 
desaturation/elongation pathway similar in effect to that observed in turbot and sea bream in 
vivo and turbot cells in vitro. Specifically,  the results show;  firstly, that the lipid and fatty acid 
composition of cell lines derived from marine fish have several features which distinguish them 
from cell lines from freshwater fish;  secondly, that one of the main factors underpinning this is 
a relative deficiency in the pathway for the desaturation and elongation of EFA in marine fish 
cells;  and thirdly, that although the effect of the deficiency is similar in different marine fish, its 
location in the pathway is  different.  
     The first feature distinguishing cells from a marine fish was the lipid class composition.  The 
SAF-1 cells cultured in 2% serum displayed a lipid content (59.8 ± 4.7 µg/106cells) comparable 
to levels previously reported in other fish cell lines cultured in 2% serum, being similar to that 
observed in Atlantic salmon (AS) cells (50.4 ± 10.0 µg/106 cells) but slightly higher than that 
found in another marine fish cell line, TF, (41.4 ± 3.3) and lower than that found in rainbow 
trout cells (RTG-2) (87.2 ± 6.0) (9,28).  However, the proportion of neutral lipids in SAF-1 cells 
(25.8%) was very similar to that found in TF cells (27.3%), both of which were much lower than 
the levels found in the freshwater fish cell lines, 37.2% and 39.2% for AS (cell line prepared 
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from freshwater fry stage) and RTG-2 cells, respectively, which were characterized by higher 
percentages of triacylglycerols (9,28).   
      Importantly however, the fatty acid composition of SAF-1 cells was characterized by the 
presence of substantial amounts of n-9PUFA, 90% of which was 18:2n-9, the most abundant 
PUFA in SAF-1 cells.  This is an identical feature to that observed in TF cells, in which 18:2n-9 
was also the most abundant PUFA and its level was increased to over 22% by reducing the 
serum supplement to 2% (9).  In contrast, 18:2n-9 is a relatively minor PUFA in AS and RTG-2 
cells amounting to only 1.2% and 1.8%, respectively, in cells cultured in 2% serum (9,28).  The 
presence of large amounts of this unusual PUFA (18:2n-9) in marine fish cells, compared to 
freshwater fish cells and mammalian cell lines, on its own strongly suggests a deficiency in fatty 
acid desaturation/elongation as a principal factor responsible for the differences in EFA 
requirements between marine and freshwater fish. 
    The higher level of total n-9PUFA in TF cells compared to AS and RTG-2 cells was 
hypothesized to be due to the marine fish cells having a higher requirement for n-3HUFA (4, 
29) and thus experiencing a greater EFA deficiency when grown in relatively n-3HUFA-
deficient, n-6PUFA-rich mammalian serum (9). This, combined with the specific location of the 
apparent deficiency in the EFA desaturation/elongation pathway in marine fish, resulted in the 
specific  accumulation of 18:2n-9 in TF cells.  Although the level of 18:2n-9 is lower than in TF 
cells, the present data in SAF-1 cells support this hypothesis and indicate that high levels of 
18:2n-9 may be a characteristic fatty acid marker for all marine fish cells in culture.  Consistent 
with the hypothesis that marine fish cells require higher levels of n-3HUFA, the two marine fish 
cell lines retained the highest proportions of n-3PUFA in their total lipid, with n-3PUFA 
accounting for 54% and 45% of total PUFA (not counting n-9PUFA) in SAF-1 and TF cells, 
respectively, but only 38% and 34% in AS and RTG-2 cells, respectively (9,28).  These 
observations in cell lines derived from marine fish are supported by the dietary traits of the 
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marine species with both sea bream and turbot being carnivorous, specifically piscivorous, 
species with diets consisting almost entirely of smaller fish and as such their natural diets are 
rich in the long-chain n-3HUFA, 20:5n-3 and 22:6n-3, (5,29,30).  In contrast, freshwater 
salmonids, such as rainbow trout, have diets richer in C18 PUFA and much lower long-chain 
HUFA (4, 29,31). 
      In contrast to the lipid and fatty acid composition data, the fatty acid “incorporation” data 
show surprisingly little difference between marine and freshwater cell lines.  The data in Table 3 
suggest that the SAF-1 cells retained [1-14C]20:5n-3 in their lipids to a greater extent than any 
other PUFA studied and that the PUFA which are present normally in only very small amounts 
in fish lipids, and are generally regarded as more transient intermediates in the PUFA pathway, 
specifically 18:4n-3, 20:3n-6 and 20:4n-3, were retained the least.  This is consistent with the 
observed fatty acid composition of fish in general, with 20:5n-3 and 22:6n-3 being the major 
PUFAs.  However, these data represent the net recovery of radioactivity in the cells after 
incubation with the fatty acid isotopes and that the radioactivity recovered will be dependent 
upon the amount of fatty acid initially taken up by the cells less the amount of fatty acid lost due 
to other metabolic processes such as oxidation or conversion to eicosanoids.  Due to the limited 
amount of pure U-14C-labelled isotopes available, they were not able to be used at exactly the 
same concentration as the 1-14C-labelled isotopes, thereby possibly affecting the amount initially 
taken up by the cells.   In addition, the 1-14C-labelled isotopes lose the radiolabel after one round 
of β-oxidation whereas the U-14C-labelled isotopes will not, also affecting the relative recoveries 
of radioactivity from the differently labelled isotopes.  Therefore, some caution is required in 
directly comparing the data in Table 3.  Previously, we have shown in several fish cell lines that 
there was little difference between the recovery of radioactivity when incubated with the 1-14C-
labelled isotopes of 18:2n-6, 18:3n-3, 20:4n-6 and 20:5n-3 (10).   
      The pattern of incorporation of the PUFA into lipid classes was very similar to that reported 
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previously in AS, RTG-2 and TF cell lines (10).  In that earlier study, 86-94%, and 96-98% of 
radioactivity from C18 PUFA and C20 PUFA, respectively, were recovered in polar lipids 
compared with figures of 88-92% for C18 PUFA and 92-98% for C20 PUFA obtained with SAF-1 
cells in the present study (10).   The preferential incorporation of C18 PUFA into PC was also 
observed in the earlier study as was the preferencial incorporation of 20:4n-6 into PI and 20:5n-
3 into PE (10).  The present study has shown that the pattern obtained with 20:3n-6 was 
basically as expected for a C20 PUFA in general, but particularly similar to 20:4n-6, whereas the 
incorporation of 20:4n-3 was more similar to that for C18 PUFA.   However, there was no major 
difference between the freshwater fish cell lines, AS and RTG-2, and the marine fish cell lines, 
TF and SAF-1, in the incorporation of PUFA into lipid classes.  These results appear to indicate 
that the ability of the cells to metabolize, or not, the fatty acids via desaturation and elongation 
does not greatly influence their uptake, retention or distribution in cell lipids, at least at the low 
concentrations used in the present study. 
     The primary aim of the present study was to determine if the deficiency in the 
desaturase/elongase pathway, established in C18-20 elongase in TF cells (11), was identical in 
another marine fish cell line.  The results obtained using the direct substrates for each individual 
enzymic activity in the pathway enabled the deficient step in SAF-1 cells to be identified.  The 
fact that 43.2% and 66.1% of added [1-14C]18:2n-6 and [1-14C]18:3n-3, respectively, were 
desaturated showed that SAF-1 cells expressed a highly active Δ6 desaturase.  In addition, 19% 
of the direct substrate for C18-20 elongase, [U-14C]18:4n-3, was elongated. In contrast, only 2.5% 
and 0.7% of added [1-14C]20:3n-6 and [U-14C]20:4n-3 were recovered as Δ5 desaturation 
products. Almost 7% and 11% of [1-14C]20:4n-6 and [1-14C]20:5n-3, respectively, were C20-22 
elongated. In summary, the apparent activities of Δ6 desaturase, C18-20 elongase and C20-22 
elongase were approximately 94-fold, 27-fold and 16-fold greater than that for Δ5 desaturase 
towards their respective n-3 polyunsaturated fatty acid substrates.  These results showed that, in 
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contrast to turbot cells, fatty acyl Δ5 desaturation was the step with the lowest activity in the 
pathway biosynthesizing 20:5n-3 (or 20:4n-6) in the sea bream cells. 
 It was noteworthy that the Δ5 desaturase activity in SAF-1 cells was particularly 
ineffective towards the n-3 substrate.  This was unexpected as desaturases in general are 
normally more active towards n-3 fatty acids in mammals (32,33) and fish cells (10,11,34).  
Furthermore, the other enzymes in the pathway, Δ6 desaturase and the C18-20 and C20-22 elongases, 
showed greater activity towards n-3PUFA in SAF-1 cells. 
Deficiencies in fatty acyl desaturase activities have precedents in terrestrial carnivores 
such as cats in which Δ6 and Δ5 desaturase activities may both be very low (35-38).  It has been 
hypothesized that this situation may be an evolutionary adaptation to carnivorous diets rich in 
preformed C20 and C22 HUFA.   This may be parallelled in fish because, as described above, the 
diets of the generally more herbivorous/omnivorous freshwater fish are rich in C18 PUFA and do 
not contain much C20 or C22 HUFA whereas marine fish which are predominantly carnivorous 
consume diets rich in 20:5n-3 and 22:6n-3 (30,31). Therefore, the differences in the fatty acid 
desaturase/elongase pathways between fish species may be an evolutionary response to dietary 
differences.  However, this cannot explain the why turbot should have low C18-20 elongase and 
sea bream low Δ5 desaturase. 
In both cases studied in marine fish, Δ5 desaturase in SAF-1 cells and C18-20 elongase in TF 
cells, it should be noted that there is not a complete lack of the enzyme activity responsible for 
the deficiency in the pathway. This is now also known to be the case in cats.  In early studies, a 
complete lack of Δ6 desaturation enzymatic activity in felines was originally reported in the 
literature (35-38), although recent and more sensitive studies conducted with deuterated fatty 
acids, showed that a low level of Δ6 desaturase is present in the cat (39). 
The present study provides good evidence that SAF-1 cells have a deficiency in fatty acyl 
Δ5 desaturase activity in contrast to turbot cells in which C18-20 elongase is deficient. Both of 
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these relative deficiencies in the fatty acid desaturation/elongation pathway are entirely 
consistent with the known EFA requirements of marine fish.   However, it is important to 
determine if this is a reflection of the situation in vivo  and that the cell lines are a model for the 
whole animal.  Studies with mammalian cell lines have shown that three out of six expressed 
little Δ6 desaturase activity, Δ5 desaturase activity appeared to be absent in four cell lines and 
only one cell line expressed any desaturation activity beyond Δ5 (40). An apparent loss of 
stearoyl-CoA Δ9 desaturase has been reported in cultured murine T lymphocytes (41).  
Therefore, experiments with stable isotopes, similar to those performed by other authors in 
felines (39) and humans (42,43) are required to confirm the deficiencies in fatty acid 
desaturation and elongation in marine fish in vivo. 
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Table 1.  Lipid content and lipid class composition (percentage  
of total lipid) of SAF-1 cells grown at 22oC in medium  
supplemented with 10% fetal calf serum. 
 
____________________________________________________ 
 
Lipid                                                                   Content          
____________________________________________________ 
 
Total lipid content 
 µg lipid /106 cells                                            59.8 ± 4.7  
 µg lipid /mg protein                                          135 ± 7  
 
Lipid class composition 
 
Phosphatidylcholine                                         29.8 ± 0.8                              
 
Phosphatidylethanolamine                                19.0 ± 0.6                              
 
Phosphatidylserine                                             6.3 ± 0.2                                
 
Phosphatidylinositol                                           7.3 ± 0.2                               
 
Phosphatidic acid/cardiolipin                              4.5 ± 0.2                              
 
Sphingomyelin                                                    2.4 ± 0.3                                
 
Sulfatides/cerebrosides                                       4.9 ± 0.3                                                                                     
 
  
Total polar lipids                                                74.2 ± 1.7                           
 
Total neutral lipids                                             25.8 ± 1.7                               
 
 
Cholesterol                                                        20.3 ± 0.7                                
 
Triacylglycerol                                                    1.7 ± 0.4                               
 
Steryl ester                                                          3.8 ± 2.0                                
 
Free fatty acids                                                         t                                    
_____________________________________________________ 
 
Results are means ± S.D. (n=3);  t, trace value (< 0.05%).  
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Table 2. Fatty acid compositions (percentage of weight)  
total lipid from SAF-1 cells grown at 22oC in medium 
supplemented with 10% fetal bovine serum. 
__________________________________________ 
                                                                                        
Fatty acid                                   Percentage                                                            
__________________________________________ 
14:0                                             1.0 ± 0.1                                                            
15:0                                             0.2 ± 0.0                                                          
16:0                                           15.0 ± 0.8                                                        
17:0                                             0.5 ± 0.2                                                  
18:0                                             8.5 ± 0.2                                                                                                              
Total saturated                            25.2 ± 1.1                                                     
16:1(n-9)                                    3.9 ± 0.5                                                          
16:1(n-7)                                    4.6 ± 0.2                                                    
18:1(n-9)                                  25.2 ± 1.0                                                  
18:1(n-7)                                    7.0 ± 0.3                                                      
20:1(n-9)                                           t                                                         
20:1(n-7)                                    0.1 ± 0.1                                                                                                                 
24:1                                            0.6 ± 0.1                                                      
Total monounsaturated             41.4 ± 1.6                                                 
18:2(n-9)                                   9.0 ± 0.9                                                   
20:2(n-9)                                   0.4 ± 0.2                                                         
20:3(n-9)                                   0.1 ± 0.1 
C22(n-9)                                   0.5 ± 0.4                                                                                                          
Total (n-9) PUFA                    10.0 ± 1.0                                                
18:2(n-6)                                  1.2 ± 0.2                                                       
18:3(n-6)                                  1.2 ± 0.2  
20:2(n-6)                                  0.1 ± 0.1                                                                
20:3(n-6)                                  1.6 ± 0.1                                                              
20:4(n-6)                                  5.4 ± 0.5                                                                                                              
Total (n-6) PUFA                     9.5 ± 0.6                                                                                                                      
18:4(n-3)                                  0.1 ± 0.1                                                            
20:4(n-3)                                  0.2 ± 0.2                                                                   
20:5(n-3)                                  1.4 ± 0.9                                                       
22:5(n-3)                                  3.5 ± 0.1                                                            
22:6(n-3)                                  5.5 ± 0.7                                                   
Total (n-3) PUFA                   10.7 ± 1.7                                                         
  
Total dimethylacetals                1.7 ± 1.5                                                     
Total PUFA                            30.2 ± 1.5                                                      
Total unidentified                     1.5 ± 0.4                                                       
__________________________________________ 
 
Results are means ± S.D. (n=3).  
PUFA, polyunsaturated fatty acids. 
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Table 3. Recovery of radioactivity in total lipid from SAF-1 cells incubated with  
14C - polyunsaturated fatty acids (PUFA). 
 
_________________________________________________________________ 
 
                                                                               Recovery 
                                                   _______________________________________                  
                                                         
14C - PUFA                               (pmol / million cells)        (pmol / mg protein)                                                                                 
_________________________________________________________________ 
 
[1-14C]18:2n-6                                 3.82 ± 0.94b                   1.14 ± 0.32b 
 
[1-14C]18:3n-3                                 3.71 ± 0.99b                   1.22 ± 0.12b       
 
[U-14C]18:4n-3                                1.36 ± 0.31c                   0.44 ± 0.10c 
 
[1-14C]20:3n-6                                 2.43 ± 0.60bc                  0.76 ± 0.10bc       
 
[1-14C]20:4n-6                                 3.14 ± 0.64bc                  1.18 ± 0.02b            
 
[U-14C]20:4n-3                                1.95 ± 0.03bc                  0.63 ± 0.01bc 
 
[1-14C]20:5n-3                                 6.53 ± 1.10a                    2.21 ± 0.46a        
_________________________________________________________________ 
 
Results are means ± SD ( n = 3).  Data were subjected to one-way analysis of variance  
followed, where appropriate, by Tukey’s multiple comparison test.  Means in the same  
column with different superscript letters are significantly different (p < 0.05).    
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Table 4. Recovery of radioactivity in lipid classes from SAF-1 cells incubated  
with 14C - polyunsaturated fatty acids (PUFA). 
 
_________________________________________________________________________ 
                                                           14C - polyunsaturated fatty acid added 
                        _____________________________________________________________ 
Lipid class                           18:2n-6                  18:3n-3                     18:4n-3 
_________________________________________________________________________ 
PC                                     51.1 ± 1.1c            51.1 ± 0.8c               70.5 ± 1.8a 
PE                                     18.1 ± 0.5e            20.4 ± 0.9de              10.2 ± 1.0f 
PS                                       5.3 ± 0.5b             4.1 ± 0.3c                 1.9 ± 0.2d 
PI                                        5.1 ± 0.1de             5.3 ± 0.5d                 3.0 ± 0.2e 
PA/CL                               12.8 ± 0.3a              8.9 ± 0.5c                 2.4 ± 0.2d 
 
TP                                     92.4 ± 0.2bc           89.8 ± 0.3cd              87.9 ± 3.2cd 
TN                                      7.6 ± 0.2ab           10.2 ± 0.3a                12.1 ± 3.2a 
_________________________________________________________________________ 
                                                        14C - polyunsaturated fatty acid added 
                        _____________________________________________________________ 
 
Lipid class               20:3n-6                  20:4n-6                      20:4n-3                  20:5n-3                   
_________________________________________________________________________ 
 
PC                        35.5 ± 0.9d            11.9 ± 1.4f                61.4 ± 2.0b             20.8 ± 1.1e               
PE                        26.6 ± 0.5c             43.0 ± 1.6b               22.0 ± 0.9d             63.2 ± 1.6a            
PS                          6.7 ± 0.3a               2.2 ± 0.2d                 1.9 ± 0.2d               2.6 ± 0.1d              
PI                         15.0 ± 1.4b             32.8 ± 1.3a                 4.6 ± 0.2de              8.8 ± 0.3c             
PA/CL                  10.8 ± 0.1b              8.1 ± 0.8c                 2.4 ± 0.3d               2.8 ± 0.1d           
 
TP                        94.7 ± 0.2b            98.1 ± 0.1ab              92.2 ± 2.9bd            98.1 ± 0.2ab           
TN                         5.3 ± 0.2bc             1.9 ± 0.1c                 7.8 ± 2.9ab               1.9 ± 0.2c               
__________________________________________________________________________  
Results are expressed as percentages of total radioactivity recovered and are means ± SD (n = 
3). Data were subjected to one-way analysis of variance followed, where appropriate, by 
Tukey’s  multiple comparison test.  Means for each individual lipid class with different 
superscript letters  are significantly different (p < 0.05). 
CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine;  PI, phosphatidylinositol; PS, phosphatidylserine; TN, total neutral 
lipids; TP, total polar lipids. 
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Table 5.  Metabolism of 14C - polyunsaturated fatty acids (PUFA) by desaturation and  
elongation in SAF-1 cells. 
_________________________________________________________________________ 
 
                                                           14C - polyunsaturated fatty acid added 
                        _____________________________________________________________ 
 
Fatty acid                          18:2n-6                            20:3n-6                         20:4n-6                                                     
_________________________________________________________________________ 
 
18:2n-6                          56.0 ± 1.6                               n.d.                             n.d.                              
20:2n-6                            0.8 ± 0.1                               n.d.                             n.d.                           
18:3n-6                          35.1 ± 1.8                               n.d.                             n.d.      
20:3n-6                            3.8 ± 0.3                         84.1 ± 0.7                         n.d.   
22:3n-6                                   t                                13.4 ± 0.8                         n.d.           
20:4n-6                            2.5 ± 0.5                           2.0 ± 0.2                  93.4 ± 1.9        
22:4n-6                            1.8 ± 0.3                           0.5 ± 0.1                    5.5 ± 1.9              
24:4n-6                                n.d.                                    n.d.                        1.1 ± 0.2           
22:5n-6                                n.d.                                      t                                  t       
_________________________________________________________________________ 
 
                                                           14C - polyunsaturated fatty acid added 
                        _____________________________________________________________ 
 
Fatty acid                 18:3n-3                18:4n-3                  20:4n-3                  20:5n-3                                    
_________________________________________________________________________ 
18:3n-3                  32.1 ± 1.0                 n.d.                        n.d.                        n.d.                     
20:3n-3                    1.9 ± 0.3                 n.d.                        n.d.                        n.d.           
18:4n-3                  40.9 ± 0.9           81.0 ± 2.0                8.3 ± 1.4                   n.d.       
20:4n-3                  20.7 ± 0.9           13.2 ± 1.4              85.8 ± 1.4                   n.d.     
22:4n-3                    4.5 ± 0.3             5.1 ± 0.2                5.2 ± 1.7                   n.d.         
18:5n-3                         n.d.                     n.d.                        n.d.                       n.d.       
20:5n-3                           t                   0.7 ± 0.5                 0.7 ± 0.4             89.0 ± 0.7           
22:5n-3                         n.d.                     n.d.                        n.d.                   9.9 ± 0.8         
24:5n-3                         n.d.                     n.d.                        n.d.                   0.6 ± 0.1          
22:6n-3                         n.d.                     n.d.                        n.d.                   0.4 ± 0.0      
_____________________________________________________________________________ 
Results are expressed as percentages of total radioactivity recovered and are means ± SD (n = 
3).  n.d., not detected; t, trace (< 0.05%).  
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Table 6. Products of desaturase and elongase activities in SAF-1 cells incubated with various  
14C-labelled polyunsaturated fatty acids 
 
_____________________________________________________________________________ 
 
     Fatty acid                 Δ6 desaturase        C18-20 elongase        Δ5 desaturase       C20-22 elongase 
       added                         products                products                  products                products 
_____________________________________________________________________________ 
 
[1-14C]18:2n-6                43.2 ± 1.5              8.9 ± 0.5                4.3 ±  0.8               1.8 ± 0.3 
 
[1-14C]18:3n-3                66.1 ± 1.1            27.1 ± 0.6                        t                      4.5 ± 0.3 
 
[U-14C]18:4n-3                       -                    19.0 ± 2.1                0.7 ± 0.5                5.1 ± 0.2 
 
[1-14C]20:3n-6                        -                            -                        2.5 ± 0.2              13.9 ± 0.7 
 
[U-14C]20:4n-3                       -                            -                        0.7 ± 0.4                5.2 ± 1.7 
 
[1-14C]20:4n-6                        -                            -                               -                       6.6 ± 1.9 
 
[1-14C]20:5n-3                        -                            -                               -                     10.9 ± 0.8 
_____________________________________________________________________________ 
Results are presented as percentages of total radioactivity recovered and are means ± SD (n=3).  
All fatty acid metabolites for a given step in the pathway were summed, irrespective of 
subsequent  metabolism by another activity (e.g. for [1-14C]18:2n-6,  “Δ6 products” represents 
the sum of  radioactivity recovered as 18:3n-6, 20:3n-6, 20:4n-6 and 22:4n-6). t, trace (< 
0.05%). 
 
